Haifeng Qiu, Ruixia Guo. "Penpulimab plus anlotinib as first-line treatment for persistent, recurrent, or metastatic cervical cancer: A multicentre, single-arm, phase II trial.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.19_suppl.211